@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix RNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:7797; a RNA: . sub:_2 occursIn: species:9606; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:50113; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:androgen) -> r(HGNC:NFKBIA)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "The level of IkappaB-alpha (NFKBIA) mRNA was decreased after castration of mice bearing CWR22 tumors. Treatment of castrated mice with TP (Testosterone pellets) restored expression of mRNA to levels seen in the intact CWR22. Further in the recurrent tumors, the levels of NFKBIA mRNA were higher than in CWR22 tumors after castration and similar to levels in androgen-stimulated tumors from intact mice."; prov:wasQuotedFrom pubmed:9865729 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:9865729; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:34:20.186+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }